Ownership history in Squarepoint Ops LLC · 31 quarters on record
This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in PUMA BIOTECHNOLOGY INC (PBYI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 21,334 | +3,540 | +19.9% | 0.00% | $113K | $5.31 |
| 2025 Q2 | REDUCED | 17,794 | -58,135 | -76.6% | 0.00% | $61K | $3.43 |
| 2024 Q4 | REDUCED | 75,929 | -23,318 | -23.5% | 0.00% | $232K | $3.05 |
| 2024 Q3 | ADDED | 99,247 | +27,856 | +39.0% | 0.00% | $253K | $2.55 |
| 2024 Q2 | ADDED | 71,391 | +10,757 | +17.7% | 0.00% | $233K | $3.26 |
| 2024 Q1 | ADDED | 60,634 | +32,236 | +113.5% | 0.00% | $321K | $5.30 |
| 2023 Q4 | REDUCED | 28,398 | -28,180 | -49.8% | 0.00% | $123K | $4.33 |
| 2023 Q3 | REDUCED | 56,578 | -34,409 | -37.8% | 0.00% | $149K | $2.63 |
| 2023 Q2 | ADDED | 90,987 | +74,137 | +440.0% | 0.00% | $321K | $3.53 |
| 2023 Q1 | REDUCED | 16,850 | -1,043 | -5.8% | 0.00% | $52K | $3.09 |
As of 2025 Q4 — sorted by position size